Monday’s Biggest Winners and Losers in the S&P 500
Monday was a solid day for the broad U.S. markets, kicking off the week on a very positive note. Crude oil was fairly volatile on the day, but ultimately ended up positive. The S&P…
All Work
Chris Lange
AFG Holdings Announces Potential Pricing for IPO
Original equipment manufacturer AFG intends to sell more than 18 million shares in an initial public offering valued up to more than $376 million.
Axovant Wins With Key Licensing Agreement
Axovant Sciences shares saw a handy gain on Monday after the company announced that it has licensed exclusive global rights to an investigational gene therapy program from Benitec Biopharma.
What to Expect When Pepsi Reports
PepsiCo is one of the first major companies to report earnings this week, with results expected Tuesday morning before the markets open.
Constellation Pharma Closes in on IPO
Constellation Pharmaceuticals intends to price more than 5 million shares to result in an initial public offering valued up to more than $98 million.
KemPharm Dips Despite Positive ADHD Trial Results
KemPharm shares dipped on Monday after the firm announced topline results from its ADHD clinical trial.
Can Groupon Get Lucky With a Buyout?
Groupon shares have been hit in 2018, but it seems that this online coupon company may have found a way to get something back. Groupon may be looking for a buyout.
Citigroup, JPMorgan, Wells Fargo and More Earnings Coming This Week
24/7 Wall St. has put together a preview of PepsiCo, Wells Fargo and some of the other top companies reporting their latest results in the coming week.
Major Biopharma Catalysts on July’s FDA Calendar
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in July.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a positive day for the broad U.S. markets, closing out an ultimately positive but shortened week. Crude oil bounced back on the day. The S&P 500 sectors were entirely positive.
Why PriceSmart Is Friday’s Big Earnings Loser
PriceSmart released mixed fiscal third-quarter financial results after the markets closed on Thursday.
Employment Situation Heats Up in June
The U.S. Department of Labor released its Employment Situation numbers for the month of June early on Friday.
Square Withdraws FDIC Application
Square announced late on Thursday that it would be withdrawing its application with the Federal Deposit Insurance Corporation (FDIC) for a banking charter.
Biogen Wins Big With Midstage Alzheimer’s Study
Biogen shares jumped early on Friday after the firm, in conjunction with Eisai, announced positive results from a midstage Alzheimer’s study.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a positive day for the broad U.S. markets, although volume and activity were not so great considering this is the day after a federal holiday. Crude oil backed off on the day.…
SEC Issues FCPA Charges Against Credit Suisse
The SEC has announced that Credit Suisse will pay roughly $30 million to resolve charges of violating the Foreign Corrupt Practices Act.
Micron Bounces Back From Chinese Lawsuit
Micron Technology announced a temporary Chinese ban on a patent infringement lawsuit. Micron’s shares dropped on Tuesday as a result but they have bounced back in Thursday’s session.
Are Xplore Shareholders Getting Enough in the Buyout?
Xplore Technologies shares spiked on Thursday after it was announced that the company would be acquired by Zebra Technologies.
Why Zynerba Shares Are Getting Crushed
Zynerba Pharmaceuticals shares were crushed early on Thursday after the company reported topline results from an early stage clinical study.
Clovis Breaks Into Europe With EMA Validation
Clovis Oncology shares saw a bump early on Thursday after the company announced that the European Medicines Agency has validated its application for a Type 2 variation to the marketing authorization for Rubraca.